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1. Introduction 
The term biomaterial, as defined by a consensus conference on Definitions in Biomaterial 
Science, is a material intended to interface with biological systems to evaluate, treat, 
augment or replace any tissue, organ of function of the body. [1] Biomaterials range from 
the simple embedded material to complex functional devices. There are three primary types 
of biomaterials: 1) metallic, based on metallic bonds, 2) ceramic, based on ionic bonds, and 3) 
polymeric, based on covalent bonds. [2] Polymers that are mechanical resistance, degradable, 
permeable, soluble and transparent, have been used in both simple and complex biomaterial 
applications. [3-5] The mechanical properties of poly(esters), poly(amides), 
poly(amidoamines), poly(methyl methacrylate), and poly(ethyleneimine), are particularly 
well suited (Table 1). These polymeric materials have given rise to first and second-
generation biomaterials. [6] ‘Next’-generation biomaterials will have less toxic degradation 
products, undergo hierarchal assemble to form supramolecular structures, and maintain a 
sustainable design. The degradation products of synthetic polymers are of acidic and cannot 
be metabolized biological systems. This can result in a bioaccumulation of these products 
offsetting the homeostatic balance of the system. The production of synthetic polymers 
requires bulk separation and crystallization, which often inhibits the formation of higher 
ordered structures. Finally, the source materials for these polymers are petrochemicals. The 
dependency on petrochemicals presents both environmental and sustainability concerns. 
The development of materials that overcome these limitations would be a significant 
advancement in the field of biomaterials. 
Biological materials have capabilities that far exceed those which are synthesized chemically. 
[21, 22] Biopolymers including polypeptides, can serve as replacement materials for synthetic 
polymers. Polypeptides such as collagen, elastin, and silk, are currently being sought as next-
generation biomaterials (Table 2). [23-28] Collagen, a major constituent of bone, cartilage, 
tendon, skin and muscle, are the most abundant proteins in the human body. [29] Several 
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different types of collagen have been identified; these proteins are distinguished by their 
triple-helical structure. Type I collagen forms supramolecular assemblies. This assembly is 
controlled by environmental parameters such as concentration, pH, and ionic strength, making 
it of particular interest as a biomaterial. [29] Type I collagen is approximately 1000 amino acids 
long and contains a tripeptide (-Pro-Hyp-Gly-)n tandem repeat, where Hyp is a 
postranslationally modified hydroxyproline. Elastin is an extracellular matrix protein 
responsible for the extensibility and elastic recoil of blood vessels, ligaments and skin. Elastin 
is approximately 70 kDa protein composed of crosslinking domains and elastin domains. 
Elastin domains are composed poly(Gly-Val-Gly-Val-Pro)n and poly(Gly-Val-Gly-Val-Ala-
Pro)n of repeating sequences. These domains undergo an inverse temperature transitions 
where the protein forms a crystalline state on raising the temperature and redissolve on 
lowering the temperature. [30, 31] Silks are fibrous proteins spun by silkworms and spiders. 
They have a range of functions, including cocoons to protecting eggs or larvae, draglines to 
support spiders, and the formation of webs that can withstand high impacts of insect prey. [32] 
The mechanical strength of dragline spider silks has led to its employment in several 
biomedical applications. Dragline spider silk is around 300 kDa protein composed of two 
repeating domains: poly(Ala)n and poly(Gly-Gly-Gly-Xaa-Gln-Tyr)n, where Xaa can be any 
amino acid. The strength of this polymer is a result of the highly crystalline structure of the 
poly(Ala) domains and the amorphous poly(Gly-Gly-Gly-Xaa-Gln-Tyr) repeat is amorphous 
in structure which allows for flexibility. [33, 34] All of three of these high molecular weight 
polypeptides are composed of highly repetitive amino acid sequences. The present review will 
be concerned with the synthesis of polypeptides and how they polypeptides will be used in 
the production of new biomaterials. 
 
Polymer Biomaterial Application Ref 
Synthetic Polymer  
Polyester Drug Delivery, Sutures, Stents, Nanoparticles [7-10] 
Polyamides Sutures, Wound Dressings [11] 
Polyamidoamine Biomedical Imaging [12] 
Poly(methyl methacrylate) Contact Lens [4] 
Polyethyleneimine Gene Delivery, Tissue Engineering [13-15] 
Natural Polymer  
Polypeptides Gene Delivery, Biomedical Imaging, Drug Delivery, [16-18] 
Polysaccharides Tissue Engineering, Nanoparticles [19] 
Polynucleotide Biomedical Imaging [20] 
Table 1. Survey of synthetic and natural polymers used as biomaterials 
 
Polypeptide Repeating Sequences MW (kDa) Ref 
Collagen (-Pro-Hyp-Gly-) n ~ 400 [29] 
Elastin 
(-Gly-Val-Gly-Val-Pro-) n, or (-Gly-Val-Gly-Ala-
Pro-) n
~ 70 [30,31] 
Spider Silk (-Ala-)n or (-Gly-Gly-Gly-Xaa-Gln-Tyr-) n ~ 300 [33,34] 
Table 2. Amino acid sequence of polypeptides being used as biomaterials 
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The synthesis of polypeptides means formation of amide bonds between amino acid 
monomers. Amide bonds are formed by a condensation reaction between a carboxylic acid 
and an amine. The conventional chemical method for amide bond synthesis requires the 
activation of the carboxyl group followed by a nucleophilic attack by a free amine. This 
requires the presence of coupling reagents, base and solvents (Figure 1A). [35] When this 
condensation reaction occurs between two amino acids the resulting amide bond is a peptide 
bond. Solid phase peptide synthesis (SPPS), developed by Merrifield, provides a fast an 
efficient manner to synthesis polypeptides. In SPPS, the N-terminal amino acid is attached to a 
solid matrix with the carboxyl group and the amine group is protected (Figure 1B). Amine 
group undergoes a deprotection step revealing an N-terminal amine. This is followed by a 
coupling reaction between the activated carboxyl group of the next amino acid and the amine 
group of the immobilized residue. Side chains of several amino acids contain functional 
groups, which may interfere with the formation of amide bonds and must be protected. This 
process may continue through iterative cycles until the polypeptide has reached its desired 
chain length. Polypeptide is then cleaved off the resin and purified. [35-37] SPPS has 
enabled the synthesis of ogliopeptides ~40 to 50 amino acids residues. However, limitations 
in chemical coupling efficiency have made it impractical to synthesize longer polypeptides 




Figure 1. Chemical synthesis of polypeptides. A) The chemical synthesis of an amide bond requires the 
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Peptide bonds, the key chemical linkage in proteins, are synthesized not only chemically but 
also biologically. In this process the primary structure of a protein is encoded in a gene, a 
short sequence of deoxyribonucleic acid (DNA). A two-step process of transcription and 
translation are required to biosynthetic extract this information from a gene. Transcription is 
the step where the genetic information encoded from the DNA is transcribed into messenger 
ribonucleic acid (mRNA) in the form of an overlapping degenerate triplet code. This process 
occurs in three stages: initiation, chain elongation, and termination. Initiation occurs when 
the RNA polymerase binds to the promoter gene sequence on the DNA strand. Elongation 
begins as the RNA polymerase is guided along the template DNA unwinding the double-
stranded DNA molecule as well as synthesizing a complementary single-stranded RNA 
molecule. Finally, transcription is terminated with the release of RNA polymerase from 
template DNA. Translation involves the decoding of the mRNA to specifically and 
sequentially link together amino acids in a growing polypeptide chain. Decoding of mRNA 
occurs in the ribosome, a macromolecular complex composed of nucleic acids and proteins. 
mRNA is read in three-nucleotide increments called codons; each codon specifies for a 
particular amino acid in the growing polypeptide chain (Figure 2). Ribosomes bind to 
mRNA at the start codon (AUG) that is recognized by initiator tRNA. Ribosomes proceed to 
elongation phase of protein synthesis. During this stage, complexes composed of an amino 
acid linked to tRNA sequentially bind to the appropriate codon in mRNA by forming 
complementary base pairs with the tRNA anticodon. Ribosome moves from codon to codon 
along the mRNA. Amino acids are added one by one, translated into polypeptide sequences 
dictated by DNA and represented by mRNA. At the end, a release factor binds to the stop 
codon, terminating translation and releasing the complete polypeptide from the ribosome. 
 
Figure 2. Cartoon representation of polypeptide synthesis on the ribosome. 
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The advent of recombinant DNA technology has allowed the facile, large-scale production 
of many polypeptide sequences. However, polypeptides containing highly repetitive 
sequences are difficult to express recombinantly due to undesirable elements in the 
secondary structure of the mRNA. [38-41] The development of techniques to synthesize high 
molecular weight polypeptide sequences in a high yield, low impact manner will 
significantly advance the field of biomaterials (Figure 3). 
 
Figure 3. Synthesis challenges facing the use of polypeptides as biomaterials. 
These current methods in polypeptides synthesis, namely, SPPS and the recombinant DNA 
technique, have significantly improved the field of biomaterials. The ‘next’ generation of 
biomaterials will require high yields of high molecular weight, repetitive sequences bearing 
modified amino acids. Below we will review the recent advances of 1) chemoenzymatic 
synthesis by protease, 2) peptide synthesis by NRPS 3) oligomerization of peptides by 
amino acid ligase, and 4) native chemical ligation, in the context of biomaterial production. 
2. Chemoenzymatic synthesis of polypeptides 
In 1898 vant’ Hoff postulated that based on the principle of reversibility of chemical 
reactions, proteases would catalyze peptide synthesis. Bergman et al. actualized this in 1938 
by successfully demonstrating the protease-mediated synthesis of Leu-Leu and Leu-Gly 
dipeptides. [42-44] Under standard conditions proteases hydrolyze peptide bonds (Figure 
4). The active sites of proteases are composed of subsites located on either side of the 
catalytic site. The geometry and electrostatic potential of these subsites influence the 
substrate specificity of these enzymes (Table 3). Protease mediated polypeptide synthesis 
proceeds through either a thermodynamically controlled synthesis (TCS) or a kinetically 
controlled synthesis (KCS). [45] TCS is a reversal of hydrolysis and requires conditions, 
which shift the equilibrium towards synthesis. Any protease is suitable for TCS, the protease 
increases the rate at which equilibrium is established but does not alter the final equilibrium. 
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[46] TCS undergoes a two-step process (Figure 5). The first step is an exergonic process 
where a proton is transferred to –COOH and –NH2. The second step is an endergonic 
condensation. Reaction conditions should be selected that ensure for optimal catalytic 
activity. Manipulation of reaction conditions is required to increase the product yield. 
Strategies such as, product precipitation, introduction of organic solvents or water 
immiscible solvents, have been employed to favor synthesis. 
 
Figure 4. Protease mediated hydrolysis of peptide bonds. A) Hydrolytic reaction scheme B) Proteases 
active site is composed of subsites (S). Each S has an affinity for residues (P). This “lock and Key” 
mechanism dictates protease specificity. 
 
Figure 5. Protease mediated polypeptide synthesis occurs either through a thermodynamically 
controlled mechanism or a kinetically controlled mechanism. 
 
Protease Class Cleavage Sequence 
α-Chymotrypsin Serine -(Trp, Tyr, Phe, Leu, 
Met)Xaa- 
Trypsin Serine -(Arg, Lys)Xaa- 
Papain Cysteine -Phe-(Leu, Val)Xaa-Xaa- 
Bromelain Cysteine -Phe-(Leu, Val)Xaa-Xaa- 
Pepsin Aspartly -Phe-(Tyr, Leu)(Leu, Phe)- 
Thermolysin Metalloproteases -Phe-(Gly, Leu)(Leu, Phe)- 
Table 3. Protease specificity. Arrows indicate cleavage site and Xaa represents an amino acid. 
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In KCS the protease acts as a transferase; it mediates the transfer of an acyl group to an 
amino acid of peptide-derived nucleophile (Figure 5). The reaction requires an activated C-
terminal ester of the substrate and a protease containing a Cys or Ser residue in the catalytic 
site. 
In aqueous conditions, homopolymers of L-amino acids and modified polypeptides 
homopolymers and heteropolymers, have been synthesized using cysteine or serine 
proteases. [47-54] This reaction is initiated by the formation of an acyl-enzyme intermediate 
between the Cys or Ser residue in the active site and the ester group on modified carboxylic 
acid. In presence of high concentration of the substrate, the free amine group of the L-amino 
acids acts as the nucleophile resulting in propagation. Water can also serve as the 
nucleophile resulting in the termination reaction (Figure 6). Under aqueous environments, 
competition between synthesis and hydrolysis is significant and reaction parameters such as 
protease activity, pH, buffer capacity, substrate concentration, and reaction time, in 
influence product formation. Several proteases hydrolyze the peptide bond between –Lys–
Xaa, where Xaa represents any amino acid. These proteases were surveyed for optimal 
conditions for oglio(L-Lys) synthesis. At pH 7.0 bromelain demonstrated a 76% monomer 
conversion rate and an average chain length (DPavg) of 3.5. Under basic conditions both the 
monomer conversion and the DPavg were reduced, 10% and 3.0, respectively. pH 10.0 was 
the optimal condition for trypsin-mediated synthesis of oglio(L-Lys); the monomer 
conversion rate was 65% and the DPavg of 2.25. At neutral pH the monomer conversion rate 
was 10% and the DPavg was below 2.0. 
 
Figure 6. Ser/Cys protease mediated polypeptide synthesis. A carboxy terminal modified amino acid 
ethyl ester serves as the monomer. Initiation occurs upon the formation of the acyl enzyme 
intermediate. In the presence of high concentrations of the substrate, the amino terminal of the 
monomer will act as the nucleophile resulting in chain length propagation. A water molecule can also 
act as the nucleophile resulting in termination of the reaction. 
Upon synthesis insoluble homopolymers of poly(L-Tyr) and poly(L-Ala) underwent self-
assembly to form macromolecular structures. [51, 54] Polypeptide crystals have been 
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observed in high molecular weight α-polypeptides synthesized by ring-opening 
polymerization. Papain-mediated polymerization of L-Tyr ethyl ester at pH 7.0 resulted in a 
homopolymer with molecular weight greater than 1,000. After 100 minutes, 100% of the 
monomer was converted to either the polypeptide or an oligomeric state. The resulting 
polymer precipitated in globular highly crystalline state. Wide-angle X-ray diffraction 
(WAXD) and scanning electron microscopy (SEM) of the crystal demonstrated rod-like 
crystal structures originated in the center and radially grew to a diameter larger than 50 μM. 
[51] Under alkaline pH L-Ala ethyl ester was polymerized into poly(L-Ala) resulting in 
higher molecular weight product as compared to those synthesized at neutral pH. These 
higher molecular polymers showed distinct β-sheet formation and were capable of fibril 
assembly. This was in stark difference to the lower molecular weight polymers that were 
composed of mostly random coils and formed submicron aggregates. 
Chemoenzymatic synthesis of low molecular weight polypeptides have been successful  
in the production of cholecystokinin and aspartame in non-aqueous media [55, 56] However 
the bulk production of high molecular weight homo- or heteropolypeptides has yet to  
be realized. Advances in enzyme and media engineering will significantly advance this 
field. 
3. Nonribosomal peptide synthetase 
Nonribosomal peptide synthetases (NRPSs) represent another enzymatic approach to 
synthesize polypeptides. NRPSs are multimodular complexes of enzymes found in lower 
organisms that assemble secondary metabolites such as polypeptides, polyketides, and 
fatty acids (Figure 7). [57] Each NRPSs module is subdivided into four catalytic domains 
1) Adenylation domain (A-domain) 2) Peptidyl carrier protein (PCP-domain) 3) 
Condensation domain (C-domain) and 4) Thioester domain (TE-domain) (Figure 7). [57] 
Initiation occurs in the A- and PCP-domains. A-domains serve as ‘gatekeepers’, 
recognizing specific amino acids (or hydroxy acids) and activating their carboxyl group in 
an ATP-dependent manner. The A domain has broad substrate recognition and allows for 
the facile incorporation of modified amino acids. [58, 59] The activated amino acids are 
transferred to the PCP-domain where they are covalently tethered to the 4′-
phosphopantetheinyl cofactor. [60] Propagation takes place at the C-domain, where the 
amino acids are linked via a condensation reaction. Termination occurs at the TE domain 
through either a hydrolysis or a cyclization reaction, resulting in a linear or cyclic 
polypeptide, respectively. [61]  
NRPSs have made significant advances in the synthesis of cyclic polypeptides and the 
ability to introduce modified amino acids will assist in the development of scaffolds for 
biomaterials. However, NRPSs produce low molecular weight polypeptides and require 
large enzymatic complexes, which are difficult to use in large-scale production of 
polypeptides. 
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Figure 7. General scheme of nonribosomal peptide synthesis (NRPS). Each NRPS module incorporates 
one amino acid into the growing peptide chain. The modules are composed of several domains: 
Adenylation domain (red) is responsible for substrate selectivity, peptidyl carrier protein domain 
(orange) and condensation domain (green) work synergistically to form the peptide bond, and thioester 
domain (blue) which terminates the reaction, resulting in either a linear or cyclic polypeptide. 
4. Amino acid ligase 
Biological synthesis of polypeptides also occurs independent of genetic information. Several 
enzymes including, folylpolyglutamate synthetase, poly-γ-glutamate synthetase, and D-
alanine: D-alanine ligase (DDL), mediate polypeptide synthesis. [62-64] These synthetases 
either produce non-α-linked amino acids or use non-natural amino acids as their substrates. 
[65-67] The reaction mechanism of these synthetases requires an ATP-dependent ligation of 
a carboxyl of one amino acid with an amino- or imino group of a second. These enzymes all 
belong to the carboxylate-amine/thiol ligase superfamily. [68] This superfamily is identified 
by structural motifs corresponding to the phosphate-binding loop and an Mg2+ binding site 
located within the ATP-binding domain. [68] 
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Cell-free biochemical studies suggest the existence of dipeptide synthetases, which form α-
peptide linkages between L-amino acids. [73, 74] Tabata et al. using in silico screening 
identified the L-amino acid ligase gene (YwfE) in Bacillus subtilis. [69] Recombinant YwfE 
(also reported as BacD, in the literature) protein demonstrated α-dipeptides synthesis 
activity, using from unprotected L-amino acids as the substrate. YwfE contains an ATP 
binding domain however this domain showed no sequence homology with aminoacyl-
tRNA synthetase or A-domains of NRPSs. The crystal structure of YwfE was refined to 2.5 Å 
and is superimposable on DDL from E. coli (PDB ID: 2DLN). [75] YwfE is divided into three 
domains: an N-terminal domain, a central domain and a C-terminal domain. The N-terminal 
and central domains are structurally similar to DDL while the C-terminal domain is 100 
residues longer and contains additional antiparallel β-sheets. [75] Critical differences were 
observed in the active site cavity of YwfE when compared to DDL: binding mode of 
dipeptide moiety, and the size and electrostatic potential of the active site. These differences 
contribute to the substrate preference for L-amino acids and play a critical role in the 
stabilization of the tetrahedral intermediate state as proposed for DDL mechanism. [75, 76]. 
The specificity of YwfE is currently limited to non-bulky, neutral residues at the N-terminus 
and bulky, neutral residues at the C-terminus. 
Using YwfE as a template sequence new L-amino acids ligases (L-AAL) have been identified 
in silico (Table 4). [70-72] RizB from B. subtilis NBRC3134 mediated the synthesis of branch 
chained L-amino acids and L-Met homo-polypeptides. [77-81] RizB also synthesized 
heteropeptides with high specificity at the N-terminal and relaxed specificity towards the C-
terminal. [70] RizB polypeptide synthesis is similar to other L-AAL however RizB uses 
amino acid monomers as well as ogliopeptides as their substrates while other L-AAL use 
only amino acids monomers. 
 
Ligase Species Preference Length Composition Ref 




Branched Oligomer Hetero- [70] 
spr0969 S. pneumoniae Branched Oligomer Hetero- [71] 
BAD_1200 B. adolescentis Aromatic Oligomer Hetero- [71] 
RimK E. coli Glutamic Acid Oligomer Homo- [72] 
Table 4. Amino acid ligases homologs, substrate specificity and products 
In a subsequent study, RizB was used as a template sequence to identify additional L-AAL 
that synthesis high molecular polypeptides. [71] spr0969 and BAD_1200 from Streptococcus 
pneumoniae and Bifidobacterium adolescentis, respectively, were identified as RizB homologs. 
spr0969 showed a modest improvement in polypeptide chain length. spr0969 
polymerization of Val resulted in six repeat units while RizB polymerization showed only 
four repeats. BAD_1200 was more promiscuous than the other L-AAL investigated. The 
activity towards branched amino acids was lower than RizB but BAD_1200 also 
polymerized aromatic amino acids. [71] 
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Ribosomal protein S6 from Escherichia coli undergoes a unique post-translation modification 
where up to six glutamic acid residues are ligated to the C-terminus. [82-84] RimK, also a 
member of carboxylate-amine/thiol ligase superfamily, mediated this post-translational 
modification. [84] In vitro analysis of RimK synthesis resulted in 46-mer (maximum length) 
of α-poly (L-Glu) at pH 9.0, 30 oC. The maximum chain length was pH dependent. 
Furthermore, RimK demonstrated strict substrate specificity for Glu. [72] 
The data reported in these manuscripts demonstrates the enzymatic synthesis of homo- and 
heteropolypeptides. Data mining has expanded both the diversity and chain length of the 
resultant polypeptides. Recently, the crystal structure YwfE has been reported which will 
assist in the development of protein design studies. Engineering the reaction media for 
enhanced solubility of the polypeptides may influence the molecular weight. 
5. Native chemical ligation 
Native chemical ligation (NCL) allows the combination of two unprotected peptide 
segments by the reaction of a C-terminal thioester with an N-terminal cysteine peptide in a 
two-step process (Figure 8). The first step is a transthioesterification where the thiolate 
group of peptide 2 attacks the C-terminal thioester of peptide 1 under mild reaction 
conditions (aqueous buffer, pH 7.0, 20 oC), resulting in a thioester intermediate. This 
intermediate rearranges by an intramolecular SN acyl shift that results in a peptide bond 
at the ligation site. [85] NCL has been employed for the synthesis of biomaterials such as 
type I collagen and hydrogels.  
 
Figure 8. Native chemical ligation, the sulfur atom of the N-terminal Cys residue of peptide 2 attacks 
the C-terminal thiol group of peptide 1 producing a thioester intermediate that rearranges to yield a 
peptide bond. 
The length of type I collagen far exceeds the length which can be synthesized by SPPS. [86] 
Recombinant expression of this protein is limited due to the high number of hydroxyproline 
residues. [87] Paramonov et. al. was able to overcome these limitations by employing an 
NCL strategy. [88] Low molecular weight (Pro-Hyp-Gly)n repeats bearing an N-terminal Cys 
residue and a C-terminal thioester were prepared by SPPS. Following NCL polymeric 
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material with Mw = 28,000, Mn = 12,000, and PDI = 2.3, were observed. Circular dichroism 
studies demonstrated that the secondary structure of the ligated collagen was in agreement 
with the native collagen. TEM studies of the ligated collagen revealed a dense network of 
fibers with diameter in the nanometer range and microns in length. These high molecular 
weight products indicated that the collagen was self-assembling in a fashion similar to 
natural collagen.  
Hydrogels are hydrophilic cross-linked polymer networks that can retain water while 
maintaining a distinct three-dimensional shape. [89] ‘Smart’ hydrogels have been designed 
which can shrink, swell or degrade based on environmental factors. These hydrogels are 
used for tissue engineering, surgical adhesives and drug delivery. [89-91] Polypeptide 
hydrogels utilize protein scaffolds such as coiled coil domains and four-helix bundles. [92] 
These scaffolds do not meet the required mechanical robustness for many biomaterial 
applications. To enhance these mechanical properties, peptide forming hydrogels were 
modulated with β-sheet forming peptides by NCL. [93] The storage modulus of the 
hydrogel with the ligated β-sheet was 48.5 kPa, five times higher than the unmodified gel. 
The hydrogels with the increased stiffness were able to support higher proliferation rates of 
primary human umbilical vein endothelial (HUVE) cells as compared to the more elastic 
hydrogels. 
NCL has been useful tool in the development of these biomaterials. However, to further 
expand this technique for the development of higher molecular weight polypeptides 
significant hurdles must be address. High molecular weight polypeptides would require 
iterative ligations with peptides bearing both an N-terminal cysteine and a C-terminal 
thioester. Under typical NCL conditions the expected product would be the cyclic peptide 
preventing the formation of larger products. [94] 
6. Conclusion and future perspectives 
As earlier noted, amide bonds are the key chemical linkage in polypeptides. In 2007 the 
American Chemical Society of Green Chemistry Institute named amide bond formation as a 
top challenge for organic chemistry. [95] Since then, several new amide bond synthesis 
reactions have been developed. These methods are less expensive and friendly to the 
environment. The further development of these reactions and the transitioning of them from 
small molecules to macromolecules will be a future prospect of developing polypeptides as 
biomaterials. 
Polypeptides represent a class of molecules, which are uniquely qualified to serve as 
biomaterials. They undergo self-assembly to form macroscopic structures and are 
synthesized from renewable resources. Chemoenzymatic synthesis, identification of new 
enzyme sequences and native chemical ligation has advanced the more traditional routes of 
polypeptide production. Despite the successes outlined above, these techniques have been 
modest in their production of new biomaterials. Progress in the development of ‘next’-
generation biomaterials will require media and protein engineering as well as combining 
these methods reviewed above. One of the major limitations in the chemoenzymatic 
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synthesis of high molecular polypeptides is the solubility of the product. Short chain 
polypeptides composed of hydrophobic amino acids precipitate out of aqueous solution, 
yielding a phase separation between enzyme and substrate. Engineering the media to 
enhance the polypeptide solubility will help achieve higher molecular weight products. 
Screening organic solvents as well as different immobilization techniques needs to be 
investigated. 
Author details 
Peter James Baker and Keiji Numata* 
Enzyme Research Team, RIKEN Biomass Engineering Program,  
RIKEN, 2-1 Hirosawa, Wako-shi, Saitama, Japan 
7. References 
[1] Williams DF (1999) The Williams Dictionary of Biomaterials. Liverpool: Liverpool 
University Press. 343 p. 
[2] Williams DF (2009) On the Nature of Biomaterials. Biomaterials. 30: p. 5897-909. 
[3] Angelova N, Hunkeler D (1999) Rationalizing the Design of Polymeric Biomaterials. 
Trends biotechnol. 17 p. 409-21. 
[4] Refojo MF (1982) Current Status of Biomaterials in Ophthalmology. Survey of 
ophthalmology. 26: p. 257-65. 
[5] Dumitriu S (2002) Polymeric Biomaterials. In: New Concepts in Polymer Science. Boca 
Raton, FL: CRC/Taylor & Francis. 1168 p. 
[6] Hench L, Polak JM (2002) Third-Generation Biomedical Materials. Science. 295: p. 1014-
7. 
[7] Seyednejad H, et al. (2011) Functional Aliphatic Polyesters for Biomedical and 
Pharmaceutical Applications. J. controlled release. 152: p. 168-76. 
[8] Postlethwait RW, Dillon ML, Reeves JW (1961) Experimental Study of Polyester Fiber 
Suture. American journal of surgery. 102: p. 706-9. 
[9] Waksman R, Pakala R (2010) Biodegradable and Bioabsorbable Stents. Curr. pharm. 
des. 16: p. 4041-51. 
[10] Lenz RW, Marchessault RH (2005) Bacterial Polyesters: Biosynthesis, Biodegradable 
Plastics and Biotechnology. Biomacromolecules. 6: p. 1-8. 
[11] Shtil'man MI (2003) Polymeric Biomaterials. In: New Concepts in Polymer Science. Boca 
Raton, FL: CRC/Taylor & Francis. 52 p. 
[12] Esfand R, Tomalia DA (2001) Poly(amidoamine) (PAMAM) Dendrimers: from 
Biomimicry to Drug Delivery and Biomedical Applications. Drug discovery today. 6: p. 
427-436. 
[13] Chung YC, et al. (2010) A Variable Gene Delivery Carrier-Biotinylated 
Chitosan/Polyethyleneimine. Biomedical materials. 5: p 650. 
                                                                                    
* Corresponding Author 
 
Polymer Science 242 
[14] Men K, et al. (2010) A Novel Drug and Gene Co-Delivery System Based on 
Poly(epsilon-caprolactone)-Poly(ethylene glycol)-Poly(epsilon-caprolactone) Grafted 
Polyethyleneimine Micelle. J. nanosci. nanotechnol. 10: p. 7958-7964. 
[15] Kuo YC, Ku IN (2009) Application of Polyethyleneimine-Modified Scaffolds to the 
Regeneration of Cartilaginous Tissue. Biotechnol. progr. 25: p. 1459-67. 
[16] Martin ME, Rice KG (2007) Peptide-Guided Gene Delivery. The AAPS journal. 9: p. E18-
29. 
[17] Nie S, et al. (2007) Nanotechnology Applications in Cancer. Annu. rev. biomed. eng. 9: 
p. 257-88. 
[18] Choe UJ, et al. (2012) Self-assembled Polypeptide and Polypeptide Hybrid Vesicles: 
from Synthesis to Application. Top. curr. chem. 310: p. 117-34. 
[19] Calvo P, et al. (1997) Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block 
Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines. Pharm. res. 14: 
p. 1431-6. 
[20] Lee KY, et al. (2010) Bioimaging of Nucleolin Aptamer-Containing 5-(N-
benzylcarboxyamide)-2'-Deoxyuridine more capable of Specific Binding to Targets in 
Cancer Cells. J. biomed. biotechnol. p. 168306. 
[21] Bar-Cohen Y (2006) Biomimetics: Biologically Inspired Technologies. Boca Raton, FL: 
CRC/Taylor & Francis. 32 p. 
[22] Dumitriu S (2002) Polymeric Biomaterials. New York: Marcel Dekker, Inc. 1168 p. 
[23] Dai M, et al. (2011) Artificial Protein Block Polymer Libraries Bearing Two SADs: Effects 
of Elastin Domain Repeats. Biomacromolecules. 12: p. 4240-6. 
[24] Haghpanah JS, et al. (2009) Artificial Protein Block Copolymers Blocks Comprising Two 
Distinct Self-Assembling Domains. Chembiochem. 10: p. 2733-5. 
[25] Kim W, Chaikof EL (2010) Recombinant Elastin-Mimetic Biomaterials: Emerging 
Applications in Medicine. Adv. drug delivery rev. 62: p. 1468-78. 
[26] Kyle S, et al. (2009) Production of Self-Assembling Biomaterials for Tissue Engineering. 
Trends biotechnol. 27: p. 423-33. 
[27] Numata K, Yamazaki S, Naga N (2012) Biocompatible and Biodegradable Dual-Drug 
Release System Based on Silk Hydrogel Containing Silk Nanoparticles. 
Biomacromolecules. in press 
[28] Pritchard EM, Kaplan DL (2011) Silk Fibroin Biomaterials for Controlled Release Drug 
Delivery. Expert opinion on drug delivery. 8: p. 797-811. 
[29] Cen L, et al. (2008) Collagen Tissue Engineering: Development of Novel Biomaterials 
and Applications. Pediatric research. 63: p. 492-6. 
[30] Urry DW (1990) Aqueous Interfacial Driving Forces in the Folding and Assembly of 
Protein (Elastin)-Based Polymers. J. am. chem. soc. 199: p. 36. 
[31] Urry DW (2002) Elastin: a Representative Ideal Protein Elastomer. Philos. trans. r. soc. 
london, ser. B. 357: p. 169-184. 
[32] Altman GH, et al. (2003) Silk-Based Biomaterials. Biomaterials. 24: p. 401-416. 
[33] Vollrath F, Knight DP (2001) Liquid Crystalline Spinning of Spider Silk. Nature. 410: p. 
541-548. 
 
Polymerization of Peptide Polymers for Biomaterial Applications 243 
[34] Rising A, et al. (2005) Spider Silk Proteins--Mechanical Property and Gene Sequence. 
Zoological science. 22: p. 273-81. 
[35] Merrifield RB (1964) Solid-Phase Peptide Synthesis. Biochemistry. 3: p. 1385-90. 
[36] Arlinghaus R, Shaefer J, Schweet R (1964) Mechanism of Peptide Bond Formation in 
Polypeptide Synthesis. PNAS. 51: p. 1291-9. 
[37] Chang CD, Meienhofer J (1978) Solid-Phase Peptide Synthesis using Mild Base 
Cleavage of N Alpha-Fluorenylmethyloxycarbonylamino Acids. Int. j. pept. protein res. 
11: p. 246-9. 
[38] Arcidiacono S, et al. (1998) Purification and Characterization of Recombinant Spider 
Silk Expressed in Escherichia coli. Appl. microbiol. biotechnol. 49: p. 31-8. 
[39] Prince JT, et al. (1995) Construction, Cloning, and Expression of Synthetic Genes 
Encoding Spider Dragline Silk. Biochemistry. 34: p. 10879-85. 
[40] Winkler S, et al. (1999) Designing Recombinant Spider Silk Proteins to Control 
Assembly. Int. j. biol. macromol. 24: p. 265-70. 
[41] Rising A, et al. (2011) Spider Silk Proteins: Recent Advances in Recombinant 
Production, Structure-Function Relationships and Biomedical Applications. Cell. mol. 
life sci. 68: p. 169-84. 
[42] Bergmann M, Fruton JS (1941) The Specificity of Proteinases. Adv. enzymol. relat. areas 
mol. biol. 1: p. 63-98. 
[43] Bergmann M, Fruton JS (1937) The Nature of Papain Activation. Science, 1937. 86(2239): 
p. 496-7. 
[44] Bergmann M, Fruton JS (1938) Some Synthetic and Hydrolytic Experiments with 
Chymotrypsin. J. Biol. Chem. 124: p. 321-329. 
[45] Lombard C, Saulnier J, Wallach JM (2005) Recent Trends in Protease-Catalyzed Peptide 
Synthesis. Protein pept lett. 12: p. 621-9. 
[46] Jakubke HD (1994) Protease-Catalyzed Peptide-Synthesis - Basic Principles, New 
Synthesis Strategies and Medium Engineering. J. Chinese Chem. Soc. 41: p. 355-370. 
[47] Soeda Y, Toshima K, Matsumura S (2003) Sustainable Enzymatic Preparation of 
Polyaspartate Using a Bacterial Protease. Biomacromolecules. 4: p. 196-203. 
[48] Li G, et al. (2006) Rapid Regioselective Oligomerization of L-Glutamic Acid Diethyl 
Ester Catalyzed by Papain. Macromolecules. 39: p. 7915-7921. 
[49] Viswanathan K, et al. (2010) Protease-Catalyzed Oligomerization of Hydrophobic 
Amino Acid Ethyl Esters in Homogeneous Reaction Media Using L-Phenylalanine as a 
Model System. Biomacromolecules. 11: p. 2152-60. 
[50] Qin X, et al. (2011) Protease-Catalyzed Oligomerization of L-Lysine Ethyl Ester in 
Aqueous Solution. ACS Catalysis. 1: p. 1022-1034. 
[51] Fukuoka T, et al. (2002) Enzymatic Polymerization of Tyrosine Derivatives. 
Biomacromolecules. 3: p. 768-74. 
[52] Li G, et al. (2008) Protease-Catalyzed Co-Oligomerizations of L-Leucine Ethyl Ester 
with L-Glutamic Acid Diethyl Ester. Macromolecules. 41: p. 7003-7012. 
[53] Aso K, Kodaka H (1992) Trypsin-Catalyzed Oligomerization of L-Lysine Esters. Biosci. 
Biotech. Biochem. 56: p. 755-758. 
 
Polymer Science 244 
[54] Baker PJ, Numata K (2012) Chemoenzymatic Synthesis of Poly(l-alanine) in Aqueous 
Environment. Biomacromolecules, 13: p. 947-951. 
[55] Ran N, et al. (2009) Chemoenzymatic Synthesis of Small Molecule Human Therapeutics. 
Curr. pharm. design. 15: p. 134-52. 
[56] Yagasaki M, Hashimoto S (2008) Synthesis and Application of Dipeptides. Appl. micro. 
and biotech. 81: p. 13-22. 
[57] Kopp F, Marahiel MA (2007) Macrocyclization Strategies in Polyketide and 
Nonribosomal Peptide Biosynthesis. Nat. prod. rep. 24: p. 735-49. 
[58] Conti E, et al. (1997) Structural Basis for the Activation of Phenylalanine in the Non-
ribosomal Biosynthesis of Gramicidin S. EMBO. 16: p. 4174-83. 
[59] Lautru S, Challis GL (2004) Substrate Recognition by Nonribosomal Peptide Synthetase 
Multi-enzymes. Microbiology. 150: p. 1629-36. 
[60] Koglin A, Walsh CT (2009) Structural Insights into Nonribosomal Peptide Enzymatic 
Assembly Lines. Nat. prod. rep. 26: p. 987-1000. 
[61] Samel SA, et al. (2006) The Thioesterase Domain of the Fengycin Biosynthesis Cluster. J. 
mol. biol. 359: p. 876-89. 
[62] Ritari SJ, et al. (1975) The Determination of Folylpolyglutamate Synthetase. Analytical 
biochem. 63: p. 118-29. 
[63] Scrimgeour KG (1986) Biosynthesis of Polyglutamates of Folates. Biochem. cell biol. 64: 
p. 667-74. 
[64] Carpenter CV, Neuhaus FC (1972) Enzymatic Synthesis of D-alanyl-D-alanine. Two 
Binding Modes for Product on D-alanine: D-alanine Ligase (ADP). Biochemistry. 11: p. 
2594-8. 
[65] Evers S, et al. (1996) Evolution of Structure and Substrate Specificity in D-alanine:D-
alanine Ligases and Related Enzymes. J. mol. evol. 42: p. 706-12. 
[66] Urushibata Y, Tokuyama S, Tahara Y (2002) Characterization of the Bacillus subtilis 
ywsC Gene, Involved in Gamma-Polyglutamic Acid Production. J. bacteriol. 184: p. 337-
43. 
[67] Sun X, et al. (1998) Structural Homologies with ATP- and Folate-Binding Enzymes in 
the Crystal Structure of Folylpolyglutamate Synthetase. PNAS. 95: p. 6647-52. 
[68] Galperin MY, Koonin EV (1997) A Diverse Superfamily of Enzymes with ATP-
Dependent Carboxylate-Amine/Thiol Ligase Activity. Protein sci. 6: p. 2639-43. 
[69] Tabata K, Ikeda H, Hashimoto S (2005) ywfE in Bacillus subtilis Codes for a Novel 
Enzyme, L-Amino Acid Ligase. J. bacteriol. 187: p. 5195-202. 
[70] Kino K, Arai T, Tateiwa D (2010) A Novel L-Amino Acid Ligase from Bacillus subtilis 
NBRC3134 Catalysed Oligopeptide Synthesis. Biosci. biotech. biochem. 74: p. 129-34. 
[71] Arai T, Kino K (2010) New L-Amino Acid Ligases Catalyzing Oligopeptide Synthesis 
from Various Microorganisms. Biosci. biotech. biochem. 74: p. 1572-7. 
[72] Kino K, Arai T, Arimura Y (2011) Poly-Alpha-Glutamic Acid Synthesis Using a Novel 
Catalytic Activity of RimK from Escherichia coli K-12. Appl. environ. microbiol. 77: p. 
2019-25. 
[73] Sakajoh M, Solomon NA, Demain AL (1987) Cell-Free Synthesis of the Dipeptide 
Antibiotic Bacilysin. J. Indust. Microbiol. 2: p. 201-208. 
 
Polymerization of Peptide Polymers for Biomaterial Applications 245 
[74] Ueda H, et al. (1987) Kyotorphin (Tyrosine-Arginine) Synthetase in Rat-Brain 
Synaptosomes. J. Biol. Chem. 262: p. 8165-8173. 
[75] Shomura Y, et al. (2012) Structural and Enzymatic Characterization of BacD, an L-
Amino Acid Dipeptide Ligase from Bacillus subtilis. Protein science 21: p. 707-716. 
[76] Fan C, et al. (1994) Vancomycin Resistance: Structure of D-alanine:D-alanine Ligase at 
2.3 A resolution. Science. 266: p. 439-43. 
[77] Senoo A, et al. (2010) Identification of Novel L-amino Acid Alpha-Ligases through 
Hidden Markov Model-based Profile Analysis. Biosci. biotech. biochem. 74: p. 415-8. 
[78] Kino K, Nakazawa Y, Yagasaki M (2008) Dipeptide Synthesis by L-amino Acid Ligase 
from Ralstonia Solanacearum. Biochem. biophys res. comm. 371: p. 536-40. 
[79] Kino K, et al. (2010) Identification and Characterization a Novel L-Amino Acid Ligase 
from Photorhabdus luminescens subsp. laumondii TT01. J. biosci. bioengin. 110: p. 39-
41. 
[80] Arai T, Kino K (2008) A Novel L-Amino Acid Ligase is Encoded by a Gene in the 
Phaseolotoxin Biosynthetic Gene Cluster from Pseudomonas syringae pv. phaseolicola 
1448A. Biosci. biotech. biochem. 72: p. 3048-50. 
[81] Kino K, et al. (2008) A Novel l-Amino Acid Ligase from Bacillus licheniformis. J. biosci. 
bioeng. 106: p. 313-5. 
[82] Kade B, Dabbs ER, Wittmannliebold B (1980) Protein Chemical Studies on Escherichia 
coli Mutants with Altered Ribosomal Protein-S6 and Protein-S7. FEBS. 121: p. 313-316. 
[83] Reeh S, Pedersen S (1979) Post-Translational Modification of Escherichia Coli Ribosomal-
Protein S6. MGG. 173: p. 183-187. 
[84] Kang WK, et al. (1989) Characterization of the Gene rimK Responsible for the Addition 
of Glutamic Acid Residues to the C-terminus of Ribosomal Protein S6 in Escherichia coli 
Ribosomal-Protein S6. 217: p. 281-8. 
[85] Dawson PE, et al. (1994) Synthesis of Proteins by Native Chemical Ligation. Science. 
266: p. 776-9. 
[86] Tickler AK, Wade JD (2007) Overview of Solid Phase Synthesis of "Difficult Peptide" 
Sequences. In: Coligan, JE, editor. Current protocols in protein science. Chapter 18. 
[87] Myllyharju J (2009) Recombinant Collagen Trimers from Insect Cells and Yeast. 
Methods mol. biol. 522: p. 51-62. 
[88] Paramonov SE, Gauba V, Hartgerink JD (2005) Synthesis of Collagen-like Peptide 
Polymers by Native Chemical Ligation. Macromolecules. 38: p. 7555-7561. 
[89] Kopecek J, Yang J (2009) Peptide-Directed Self-Assembly of Hydrogels. ACTA 
biomaterialia. 5: p. 805-16. 
[90] Cushing MC, Anseth KS (2007) Hydrogel Cell Cultures. Science. 316: p. 1133-1134. 
[91] Jackson MR (1996) Tissue sealants: Current Status, Future Potential. Nature medicine. 2: 
p. 637-8. 
[92] Banta S, Wheeldon IR, Blenner M (2010) Protein Engineering in the Development of 
Functional Hydrogels. Ann. rev. of biomed. engin. 12: p. 167-86. 
[93] Jung JP, et al. (2008) Modulating the Mechanical Properties of Self-Assembled Peptide 
Hydrogels via Native Chemical Ligation. Biomaterials. 29: p. 2143-51. 
 
Polymer Science 246 
[94] Tam JP, Xu J, Eom KD (2001) Methods and Strategies of Peptide Ligation. Biopolymers. 
60: p. 194-205. 
[95] Constable DJC, et al. (2007) Key Green Chemistry Research Areas – A Perspective from 
Pharmaceutical Manufactures. Green chem. 9: p. 411-420. 
